How have URGN and VERA total returns compared?

Over the past 5 years, URGN delivered 20.32% and VERA delivered 14.09% annualized total return. Past performance doesn't predict future results.

UroGen Pharma Ltd. (URGN) vs Vera Therapeutics, Inc. (VERA)

A side-by-side comparison of UroGen Pharma Ltd. and Vera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

URGN

UroGen Pharma Ltd.

$2.01B

$41.25HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT

VERA

Vera Therapeutics, Inc.

$2.10B

$29.23HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT

Total return — URGN vs VERA

growth of $100 · dividends reinvested · last 5y

URGN +181.4% (+23.0%/yr)VERA +159.4% (+21.0%/yr)URGN compounded faster over this window

URGN VERA

URGN vs VERA: by the numbers

•VERA is the larger company ($2.10B vs $2.01B market cap).
•Both run net losses; VERA's is the smaller (0.00% vs -51.73% net margin).

Metrics side by side

Valuation

Metric	URGN	VERA
P/S ratio	10.65	N/A
P/B ratio	N/A	5.15

Profitability

Metric	URGN	VERA
Gross margin	90.85%	0.00%
Operating margin	-113.73%	0.00%
Net margin	-51.73%	0.00%
ROE	N/A	-98.56%
ROIC	-34.96%	-85.78%

Growth (annualized)

Metric	URGN	VERA
Revenue CAGR (5Y)	42.66%	N/A
Total return CAGR (5Y)	20.32%	14.09%

Frequently asked

How have URGN and VERA total returns compared?: Over the past 5 years, URGN delivered 20.32% and VERA delivered 14.09% annualized total return. Past performance doesn't predict future results.

Go deeper

Full URGN analysis Full VERA analysis Interactive comparison tool

Dig into the metrics

UroGen Pharma ROE Vera Therapeutics ROE UroGen Pharma operating margin Vera Therapeutics operating margin UroGen Pharma revenue growth Vera Therapeutics revenue growth UroGen Pharma free cash flow Vera Therapeutics free cash flow

UroGen Pharma & Vera Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.